VistaGen Therapeutics to Report Fiscal Year 2022 Second Quarter Financial Results and Recent Developments on November 10, 2021
Event: VistaGen Therapeutics Fiscal Year 2022 Second Quarter Financial Results and Recent Developments Conference Call and Webcast
Date: Wednesday, November 10, 2021
Time: 5:00 p.m. Eastern Time
International Dial-in (Toll): 1-201-493-6779
Conference ID: 13724394
A live audio webcast of the conference call will be available. Participants should access this webcast site 10 minutes before the start of the call. In addition, a telephone playback of the call will be available after approximately 8:00 p.m. Eastern Time on Wednesday, November 10, 2021. To listen to the replay, call toll free 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally (toll). Please use the replay PIN number 13724394.
VistaGen is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's CNS drug candidates has a differentiated profile and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com and connect with VistaGen on Twitter, LinkedIn, and Facebook.
VistaGen Company Contacts
Vice President, Corporate Development
Phone: (650) 577-3606
Phone: (615) 414-8668
Vice President, Investor Relations
Phone: (650) 577-3617
Source: VistaGen Therapeutics, Inc.